Serena Shao, head of China healthcare research at Credit Suisse, talks about Chin's health-care stocks. The country's drug stocks continue slide, extending losses to 16% over the past four trading days, after the government confirmed prices in a centralized tender fell by an average 52% from a year earlier. She speaks with David Ingles and Rishaad Salamat on "Bloomberg Markets: Asia." (Source: Bloomberg)